Shawn M. Guertin

Shawn M. Guertin filed 35 disclosures, 26 of them at Aetna Inc /PA/ as Exec. Vice President, CFO. The five sales, all at Aetna, total EUR 8,368,353 with a median of EUR 1,129,633: EUR 3,948,691 on August 22, 2016, then EUR 1,419,735 on March 21, 2017 and EUR 1,129,633 the next day. No purchase is recorded.

The other filings come from board seats (Davita Inc. with 3 filings, Trinet Group, Inc. with 3 and Evolent Health, Inc. with 2, all as director) and one filing at CVS Health Corp, where the title on file is EVP & Chief Financial Officer. The whole set includes 15 share grants, 9 option exercises and 6 filings of another kind, published from February 3, 2016 to June 8, 2026.

The pace is highest in 2017 (11 filings) and 2018 (9). A single filing falls in the last twelve months, with no sale. Publication comes a median of 2 days after the trade.

Trades by Guertin within 30 days of colleagues at Aetna Inc /PA/ number 3, 3 and 2. Every one in the same direction. Names in order: Francis S. Soistman Jr., Margaret M. McCarthy and Jeffrey E. Garten.